Post-Operative Biomarker-Guided Precision Medicine For Cardiovascular Risk Reduction

NCT06961630 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

RECRUITING

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Myocardial Injury After Noncardiac Surgery

Interventions

DRUG: Rivaroxaban
DRUG: Atorvastatin

Sponsor

NYU Langone Health

Collaborators

[object Object]